FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

2156711000001104: Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25181901000001116 Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
25182001000001112 Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
54105901000001117 Zomig 2.5mg tablets (AstraZeneca UK Ltd) 6 tablet 2 x 3 tablets en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
112399201000001110 Zomig 2.5mg tablets (Grunenthal Ltd) 6 tablet 2 x 3 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets Is a Zolmitriptan 2.5mg tablets 6 tablet true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets Is pack of Zomig 2.5mg tablets (AstraZeneca) false Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets Has active ingredient Zolmitriptan false Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets Has AMP Zomig 2.5mg tablets (AstraZeneca) true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets Has specific active ingredient Zolmitriptan true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 6 tablet 2 x 3 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start